Immunohistochemical analysis for histopathological subtypes in pediatric medulloblastomas

被引:12
作者
Son, EI
Kim, IM
Kim, DW
Yim, MB
Kang, YN
Lee, SS
Kwon, KY
Suh, SI
Kwon, TK
Lee, JJ
Kim, DS
Kim, SP
机构
[1] Keimyung Univ, Dept Pathol, Sch Med, Jung Gu 700712, Daegu, South Korea
[2] Keimyung Univ, Dept Neurosurg, Sch Med, Jung Gu 700712, Daegu, South Korea
[3] Keimyung Univ, Inst Med Sci, Sch Med, Jung Gu 700712, Daegu, South Korea
[4] Yeungnam Univ, Dept Pathol, Sch Med, Deagu, South Korea
关键词
anaplasia; histopathology; immunohistochemistry; medulloblastoma; pediatric; subtype;
D O I
10.1046/j.1440-1827.2003.01444.x
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Medulloblastomas occurring in children represent a histological spectrum of varying anaplasia and nodularity. In order to determine whether immunohistochemical markers might be useful parameters in subclassifying these tumors, 17 pediatric medulloblastomas, including nine diffuse/non-anaplastic, four diffuse/anaplastic, three nodular/non-anaplastic and one nodular/anaplastic subtypes, were studied. In the present report, we investigate the expression of neural cell adhesion molecule (NCAM), nerve growth factor receptor (NGFR), neurofilament (NF), synaptophysin (SYN), glial fibrillary acidic protein (GFAP), S100, Bcl-2, and Ki-67 by using the immunohistochemistry against specific antibodies. This study showed that NGFR, NF, GFAP and S100 were not detected in anaplastic subtypes of medulloblastomas (0/5), while non-anaplastic subtypes were mainly expressed within the nodules. All 17 tumors were reactive for NCAM, SYN and Bcl-2. In addition, Ki-67 labeling indices for anaplastic subtypes (39.0 +/- 7.42%) were significantly higher than that of non-anaplastic medulloblastomas (11.4 +/- 8.04%; P < 0.0001). These results suggest that immunohistochemical markers are a useful adjunct in characterizing subtypes of pediatric medulloblastomas.
引用
收藏
页码:67 / 73
页数:7
相关论文
共 33 条
  • [1] BAKER DL, 1991, AM J PATHOL, V139, P115
  • [2] DIFFERENTIATION IN THE MEDULLOBLASTOMA - A HISTOLOGICAL AND IMMUNOHISTOCHEMICAL STUDY
    BURGER, PC
    GRAHMANN, FC
    BLIESTLE, A
    KLEIHUES, P
    [J]. ACTA NEUROPATHOLOGICA, 1987, 73 (02) : 115 - 123
  • [3] CHATTY EM, 1971, CANCER-AM CANCER SOC, V28, P977, DOI 10.1002/1097-0142(1971)28:4<977::AID-CNCR2820280422>3.0.CO
  • [4] 2-7
  • [5] GLIAL DIFFERENTIATION IN MEDULLOBLASTOMAS - HISTOGENETIC INSIGHT, GLIAL REACTION, OR INVASION OF BRAIN
    COFFIN, CM
    MUKAI, K
    DEHNER, LP
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1983, 7 (06) : 555 - 565
  • [6] COFFIN CM, 1990, MODERN PATHOL, V3, P164
  • [7] Diebold J, 1996, AM J CLIN PATHOL, V105, P341
  • [8] Histopathologic grading of medulloblastomas - A pediatric oncology group study
    Eberhart, CG
    Kepner, JL
    Goldthwaite, PT
    Kun, LE
    Duffner, PK
    Friedman, HS
    Strother, DR
    Burger, PC
    [J]. CANCER, 2002, 94 (02) : 552 - 560
  • [9] Apoptosis, neuronal maturation, and neurotrophin expression within medulloblastoma nodules
    Eberhart, CG
    Kaufman, WE
    Tihan, T
    Burger, PC
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2001, 60 (05) : 462 - 469
  • [10] FIGARELLABRANGER DF, 1990, CANCER RES, V50, P6364